2291 Stock Overview
An investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$17.78 |
| 52 Week High | HK$29.80 |
| 52 Week Low | HK$13.00 |
| Beta | -0.70 |
| 1 Month Change | 6.59% |
| 3 Month Change | 29.40% |
| 1 Year Change | -34.51% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2291 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 1.4% | -1.6% | -0.5% |
| 1Y | -34.5% | -27.9% | 19.9% |
Return vs Industry: 2291 underperformed the Hong Kong Medical Equipment industry which returned -27.9% over the past year.
Return vs Market: 2291 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 2291 volatility | |
|---|---|
| 2291 Average Weekly Movement | 9.1% |
| Medical Equipment Industry Average Movement | 9.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2291 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2291's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 239 | Juan Chen | www.scientechmed.com |
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Fundamentals Summary
| 2291 fundamental statistics | |
|---|---|
| Market cap | HK$6.17b |
| Earnings (TTM) | HK$230.40m |
| Revenue (TTM) | HK$435.50m |
26.8x
P/E Ratio14.2x
P/S RatioIs 2291 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2291 income statement (TTM) | |
|---|---|
| Revenue | CN¥408.64m |
| Cost of Revenue | CN¥40.90m |
| Gross Profit | CN¥367.75m |
| Other Expenses | CN¥151.56m |
| Earnings | CN¥216.19m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 89.99% |
| Net Profit Margin | 52.90% |
| Debt/Equity Ratio | 0% |
How did 2291 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield91%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|